Protease-activated receptors: Sentries for inflammation?

Trends in Pharmacological Sciences

Volumn 21, Issue 3, 2000, Pages 103-108

  Cocks, Tom M ^a   Moffatt, James D ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; THROMBIN; TRYPSIN;

CELL PROTECTION; ENDOTHELIUM CELL; EPITHELIUM CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; ENZYME ACTIVATORS; HUMANS; INFLAMMATION; RECEPTOR, PAR-1; RECEPTORS, CELL SURFACE; RECEPTORS, THROMBIN;

EID: 0034161592     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(99)01440-6     Document Type: Review

References (46)

1. Coughlin S.R. How the protease thrombin talks to cells. Proc. Natl. Acad. Sci. U. S. A. 96:1999;11023-11027.
2. Dèry O.et al. Proteinase-activated receptors: novel mechanisms of signalling by serine proteases. Am. J. Physiol. 274:1998;C1429-C1542.
3. Kawabata A.et al. Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Br. J. Pharmacol. 125:1998;419-422.
4. Vergnolle N.et al. Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1. Br. J. Pharmacol. 126:1999;1262-1268.
5. Vergnolle N.et al. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR-2)-activating peptides in the rat paw. Br. J. Pharmacol. 127:1999;1083-1090.
6. Vergnolle N. Proteinase-activated receptor-2 activating peptides induce leukocyte rolling, adhesion and extravasation in vivo. J. Immunol. 163:1999;5064-5069.
7. Cicala C.et al. Bronchoconstrictor effect of thrombin and thrombin receptor activating peptide in guinea pigs in vivo. Br. J. Pharmacol. 126:1999;478-484.
8. Bu G.et al. Cellular receptors for the plasminogen activators. Blood. 83:1994;3427-3436.
9. Altieri D.C. Xa receptor EPR-1. FASEB J. 9:1995;860-865.
10. Hollenberg M.D. Protease-activated receptors: PAR4 and counting: how long is the course? Trends Pharmacol. Sci. 20:1999;271-273.
11. Lefer A.M., Lefer D.J. Nitric oxide II: nitric oxide protects in intestinal inflammation. Am. J. Physiol. 276:1999;G572-G575.
12. Eberhart C.E., Dubois R.N. Eicosanoids and the gastrointestinal tract. Gastroenterology. 109:1995;285-301.
13. Perretti M. Endogenous mediators that inhibit leukocyte-endothelium interactions. Trends Pharmacol. Sci. 18:1997;418-425.
14. Collins P.W.et al. von Willebrand factor release and P-selectin expression is stimulated by thrombin and trypsin but not IL-1 in cultured human endothelial cells. Thromb. Haemost. 70:1993;346-350.
15. Saifeddine M.et al. Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor. Br. J. Pharmacol. 125:1998;1445-1454.
16. Hamilton J.R.et al. Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries. Circ. Res. 82:1998;1306-1311.
17. Garcia J.G.et al. Regulation of thrombin-mediated endothelial cell contraction and permeability. Semin. Thromb. Hemost. 22:1996;309-315.
18. Wang H-S.et al. Endothelial cells exhibit differential chemokinetic and mitogenic responsiveness to α-thrombin. J. Surg. Res. 68:1997;139-144.
19. Cupit L.D.et al. Proteolytically activated receptor-3: a member of an emerging gene family of protease receptors expressed on vascular endothelial cells and platelets. Trends Cardiovasc. Med. 9:1999;42-48.
20. Fox M.T.et al. Identification of potential activators of proteinase-activated receptor-2. FEBS Lett. 417:1997;267-269.
21. Koshikawa N.et al. Expression of trypsin in vascular endothelial cells. FEBS Lett. 409:1997;442-448.
22. Schwartz L.B.et al. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J. Clin. Invest. 83:1989;1551-1555.
23. Moffatt J.D., Cocks T.M. Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries. Br. J. Pharmacol. 125:1998;591-594.
24. Sobey C.G., Cocks T.M. Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo. Stroke. 29:1998;1439-1444.
25. Damiano B.P.et al. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J. Pharmacol. Exp. Ther. 288:1999;671-678.
26. D'Andrea M.R.et al. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J. Histochem. Cytochem. 46:1998;157-164.
27. Molino M.et al. Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 18:1998;825-832.
28. Bono F.et al. Induction of vascular smooth muscle cell growth by selective activation of the proteinase activated receptor-2 (PAR-2). Biochem. Biophys. Res. Commun. 241:1997;762-764.
29. Alm A.K.et al. Stimulation of proteinase activated receptor-2 causes endothelial cells to promote blood coagulation in vitro. Thromb. Haemost. 81:1999;984-988.
30. Langer F.et al. Endothelial protease-activated receptor-2 induces tissue factor expression and von Willebrand factor release. Br. J. Haematol. 105:1999;542-550.
31. Vergnolle N.et al. Proteinase-activated receptor-2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc. Natl. Acad. Sci. U. S. A. 95:1998;7766-7771.
32. Nguyen T.D.et al. Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J. Clin. Invest. 103:1999;261-269.
33. Cocks T.M.et al. A protective role for protease-activated receptors in airways. Nature. 398:1999;156-160.
34. Persson C.G.A.et al. Contribution of plasma-derived molecules to mucosal immune defense, disease and repair in the airways. Scand. J. Immunol. 47:1998;302-313.
35. Koshikawa N.et al. Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am. J. Pathol. 153:1998;937-944.
36. Wang X-C.et al. Chymotrypsin gene expression in rat peripheral organs. Cell Tissue Res. 292:1998;345-354.
37. Yamada T., Nagai Y. Immunohistochemical studies of human tissues with antibody to factor Xa. Histochem. J. 28:1996;73-77.
38. Yasuoka S.et al. Purification, characterization, and localization of a novel trypsin-like protease found in the human airway. Am. J. Respir. Cell Mol. Biol. 16:1997;300-308.
39. Okajima K., Uchiba M. The anti-inflammatory properties of antithrombin III: new therapeutic implications. Semin. Thromb. Hemost. 24:1998;27-32.
40. Sower L.E.et al. Thrombin peptide, TP508, induces differential gene expression in fibroblasts through a nonproteolytic activation pathway. Exp. Cell Res. 247:1998;422-431.
41. Schmidt V.A.et al. The human proteinase-activated receptor-3 (PAR-3) gene: identification within a PAR gene cluster and characterization in vascular endothelial cells and platelets. J. Biol. Chem. 273:1998;15061-15068.
42. Cicala C.et al. Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation. 99:1999;2590-2597.
43. Vervloet M.G.et al. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin. Thromb. Hemost. 24:1998;33-44.
44. Vanhoutte P.M. Endothelial dysfunction in hypertension. J. Hypertens. (Suppl.). 14:1996;S83-S93.
45. Tomiyama H.et al. Relationship between endothelial function and fibrinolysis in early hypertension. Hypertension. 31:1998;321-327.
46. Sobey C.G.et al. Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation. Stroke. 30:1999;1933-1941.